Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Twitter Inc (NYSE: TWTR) can be an extremely useful and tradable tool for investors, but only if you follow the right people.
Here’s a look at 11 biotech and pharmaceutical company CEOs that have the potential for market-moving tweets.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
1. Brent Saunders - @brentlsaunders
Saunders is the head of Allergen plc Ordinary Shares (NYSE: AGN), a $100 billion drug company that makes eye care, skin care and aesthetic products such as Botox.
2. Richard Pops - @popsalks
The CEO of Alkermes Plc (NASDAQ: ALKS) is an active tweeter, and his company has a portfolio of about 20 drug candidates for treatment of central nervous system disorders.
3. Daphne Zohar - @daphnezohar
The CEO of Puretech Health frequently tweets about “medicine, startups, financing & other things that seem interesting.”
4. Jeff Stein - @jefflstein
Stein is the CEO of Cidara Therapeutics Inc (NASDAQ: CDTX) and actively tweets about biotech news. Cidara is developing anti-infectives with a focus on serious fungal infections.
5. Hans Bishop - @HansBishop1
Bishop is the CEO of Juno Therapeutics Inc (NASDAQ: JUNO), one of many biotech companies working on novel treatments for cancer.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
Related Link: 10 CEOs You Need To Follow On Twitter
6. Tim Mayleben - @TimMayleben
Mayleben is the CEO of Esperion Therapeutics Inc (NASDAQ: ESPR), a biotech company working on treatments for patients with elevated low-density lipoprotein cholesterol (LDL-C).
7. Katrine Bosley - @ksbosley
Bosley is the CEO of Editas Medicine Inc (NASDAQ: EDIT), a genome editing company focused on correcting disease-causing genes.
8. Brian Culley - @CEO_Culley
Culley is the CEO of Mast Therapeutics Inc (NYSE: MSTX), a biopharmaceutical company focused on treating life-threatening conditions such as sickle cell disease and heart failure.
9. Christian Homsy - @ChristianHomsy
The CEO of Celyad SA (ADR) (NASDAQ: CYAD) has just 31 tweets since 2012, but they are all biotech news items relevant for traders.
10. Paul Tunnah - @pharmaphorum
Tunnah’s company pharmaphorum isn’t actually performing biotech R&D. Instead, it’s a digital pharmaceutical communication platform with exclusive news stories written by healthcare writers.
11. Stephane Bancel - @sbancel
Bancel is the CEO of Modena Therapeutics, a private company that focuses on messenger RNA applications. Bancel often tweets about biotech news and financial markets.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.